Gene, Cell and Tissue

Published by: Kowsar

Individuals With Normal GLA Gene Sequence May Present Abnormally Spliced Alpha-Galactosidase mRNA Transcripts

Susana Ferreira 1 , * , Miguel Viana-Baptista 2 , Daniel Rodrigues 3 and Joao Paulo Oliveira 1 , 4 , 5
Authors Information
1 Department of Genetics, Faculty of Medicine, University of Porto, Oporto, Portugal
2 Department of Neurology, Egas Moniz Hospital, Lisbon, Portugal
3 Institute for Molecular and Cell Biology, Oporto, Portugal
4 Medical Genetics Outpatient Clinic, Sao Joao Hospital Centre, Oporto, Portugal
5 Nephrology Research and Development Group, University of Porto, Oporto, Portugal
Article information
  • Gene, Cell and Tissue: January 01, 2016, 3 (1); e34386
  • Published Online: December 31, 2015
  • Article Type: Research Article
  • Received: November 4, 2015
  • Revised: November 18, 2015
  • Accepted: November 22, 2015
  • DOI: 10.5812/gct.14832

To Cite: Ferreira S, Viana-Baptista M, Rodrigues D, Oliveira J P. Individuals With Normal GLA Gene Sequence May Present Abnormally Spliced Alpha-Galactosidase mRNA Transcripts, Gene Cell Tissue. 2016 ; 3(1):e34386. doi: 10.5812/gct.14832.

Copyright © 2015, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Desnick RJ, Ioannou YA. The metabolic and molecular basis of inherited disease. 2001; : 3733-74[DOI]
  • 2. Germain DP. Fabry disease. Orphanet J Rare Dis. 2010; 5: 30[DOI][PubMed]
  • 3. Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004; 337(2): 319-35[DOI][PubMed]
  • 4. Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002; 70(4): 994-1002[DOI][PubMed]
  • 5. Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin Nephrol. 2002; 57(1): 1-8[PubMed]
  • 6. Lyon MF. X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl. 2002; 91(439): 107-12[PubMed]
  • 7. Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, et al. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab. 2008; 93(2): 112-28[DOI][PubMed]
  • 8. Filoni C, Caciotti A, Carraresi L, Donati MA, Mignani R, Parini R, et al. Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. Eur J Hum Genet. 2008; 16(11): 1311-7[DOI][PubMed]
  • 9. Baptista MV, Ferreira S, Pinho-e-Melo T, Carvalho M, Cruz VT, Carmona C, et al. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients. Stroke. 2010; 41(3): 431-6[DOI][PubMed]
  • 10. Oliveira JP, Ferreira S, Barcelo J, Gaspar P, Carvalho F, Sa Miranda MC, et al. Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human alpha-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians. J Inherit Metab Dis. 2008; 31 Suppl 2-53[DOI][PubMed]
  • 11. Gaspar P, Herrera J, Rodrigues D, Cerezo S, Delgado R, Andrade CF, et al. Frequency of Fabry disease in male and female haemodialysis patients in Spain. BMC Med Genet. 2010; 11: 19[DOI][PubMed]
  • 12. Cowper AE, Caceres JF, Mayeda A, Screaton GR. Serine-arginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing. J Biol Chem. 2001; 276(52): 48908-14[DOI][PubMed]
  • 13. Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013; 14(3): 153-65[DOI][PubMed]
  • 14. Chen L, Tovar-Corona JM, Urrutia AO. Alternative splicing: a potential source of functional innovation in the eukaryotic genome. Int J Evol Biol. 2012; 2012: 596274[DOI][PubMed]
  • 15. Gamazon ER, Stranger BE. Genomics of alternative splicing: evolution, development and pathophysiology. Hum Genet. 2014; 133(6): 679-87[DOI][PubMed]
  • 16. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A. 2003; 100(1): 189-92[DOI][PubMed]
  • 17. Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ. Dynamic integration of splicing within gene regulatory pathways. Cell. 2013; 152(6): 1252-69[DOI][PubMed]
  • 18. Schweingruber C, Rufener SC, Zund D, Yamashita A, Muhlemann O. Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta. 2013; 1829(6-7): 612-23[DOI][PubMed]
  • 19. Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J, et al. Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum Mutat. 2007; 28(2): 150-8[DOI][PubMed]
  • 20. Douglas AG, Wood MJ. RNA splicing: disease and therapy. Brief Funct Genomics. 2011; 10(3): 151-64[DOI][PubMed]
  • 21. Daitx VV, Mezzalira J, Goldim MP, Coelho JC. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma. Clin Biochem. 2012; 45(15): 1233-8[DOI][PubMed]
  • 22. Lai LW, Whitehair O, Wu MJ, O'Meara M, Lien YH. Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease. Clin Genet. 2003; 63(6): 476-82[PubMed]
  • 23. Liu HX, Zhang M, Krainer AR. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 1998; 12(13): 1998-2012[DOI]
  • 24. Apelland T, Gude E, Strom EH, Gullestad L, Eiklid KL, Mansson JE, et al. Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease. Heart. 2014; 100(22): 1793-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments